Each year, 500,000 people die of malaria annually, a preventable disease. Most of them children in Africa, where many anti-malarial drugs are fake or substandard.
After an exceptional period of success in global malaria control, the progress has stalled. New strategies are needed to suit a variety of transmission patterns.
Eliminating malaria in Africa has been held back by a range of factors, including a lack of funds and drug and insecticide resistance challenges.
Firms with a focus on the domestic and regional market have an incentive to distribute their medicines effectively. Local production can create a win-win situation for health and employment.